Cargando…

“Take it up a NOTCH: ” Novel strategies for cancer therapy

Detalles Bibliográficos
Autores principales:	Morgan, Stefanie L., Wyant, Gregory A., Dinulescu, Daniela M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Editorials: Cell Cycle Features
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575440/ https://www.ncbi.nlm.nih.gov/pubmed/23287472 http://dx.doi.org/10.4161/cc.23375

Ejemplares similares

The dual nature of Notch in tissue homeostasis and carcinogenesis
por: Valdez, Joseph M., et al.
Publicado: (2013)

EZH2 takes the stage when BRCA1 loses
por: Wang, Lan, et al.
Publicado: (2013)

The CDK-activating kinase Cdk7: Taking yes for an answer
por: Schachter, Miriam Merzel, et al.
Publicado: (2013)

Zip it up to shut it down
por: Zhu, Xuan, et al.
Publicado: (2014)

Revealing targeted therapeutic opportunities in triple-negative breast cancers: A new strategy
por: Poage, Graham M, et al.
Publicado: (2013)

Up-regulation of LYAR blocks Myc-induced cell death
por: Qiu, Shenglong, et al.
Publicado: (2017)

Skp2: A dream target in the coming age of cancer therapy
por: Chan, Chia-Hsin, et al.
Publicado: (2014)

How does C/EBPα speed up cell reprogramming?
por: Sardina, Jose Luis, et al.
Publicado: (2016)

Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
por: Lyssiotis, Costas A., et al.
Publicado: (2013)

Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy
por: Osawa, Tsuyoshi, et al.
Publicado: (2013)

Steady-state neutrophil homeostasis is a demand-driven process
por: Wirths, Stefan, et al.
Publicado: (2013)

A novel link of Mediator with DNA repair
por: Soutourina, Julie, et al.
Publicado: (2014)

The oncogenic transcription factor FOXM1 and anticancer therapy
por: Gartel, Andrei L.
Publicado: (2012)

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies
por: Iwanami, Akio, et al.
Publicado: (2013)

MicroRNAs and the cellular response to rapamycin: Potential role in diagnosis and therapy
por: Totary-Jain, Hana, et al.
Publicado: (2013)

Integrin-linked kinase in ciliary Hedgehog signaling
por: Hannigan, Gregory E
Publicado: (2014)

Toward the realization of cell therapy: The advent of MAIT cells from iPSCs
por: Wakao, Hiroshi, et al.
Publicado: (2013)

Interfering with type I Interferon: A novel approach to purge persistent viral infection
por: Wilson, Elizabeth B, et al.
Publicado: (2013)

How not to get cross(ed): A novel role for FANCM orthologs in meiotic recombination
por: Lorenz, Alexander, et al.
Publicado: (2012)

Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?
por: Cowell, Ian G., et al.
Publicado: (2012)

Transactivation by low and high levels of human p53 reveals new physical rules of engagement and novel super-transactivation sequences
por: Menendez, Daniel, et al.
Publicado: (2012)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

A novel G(1) checkpoint mediated by the p57 CDK inhibitor and p38 SAPK promotes cell survival upon stress
por: Joaquin, Manel, et al.
Publicado: (2012)

“Sister” miRNAs in cancers
por: Wahdan-Alaswad, Reema, et al.
Publicado: (2013)

Vaccines and early breast cancer
por: Caballero, Otavia L, et al.
Publicado: (2014)

Targeting LIM kinase in cancer and neurofibromatosis
por: Rak, Roni, et al.
Publicado: (2014)

MET in ovarian cancer: Metastasis and resistance?
por: Tang, Chad, et al.
Publicado: (2014)

Targeting genetic lesions in esophageal cancer
por: Lin, De-Chen, et al.
Publicado: (2014)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

TLS/FUS: A protein in cancer and ALS
por: Tan, Adelene Y., et al.
Publicado: (2012)

Oxidizing to death: Disulfiram for cancer cell killing
por: Brüning, Ansgar, et al.
Publicado: (2014)

Cancer germline gene activation: Friend or foe?
por: McFarlane, Ramsay J, et al.
Publicado: (2014)

BETting on a new prostate cancer treatment
por: Asangani, Irfan A, et al.
Publicado: (2014)

Restoring PML tumor suppression to combat cancer
por: Wolyniec, Kamil, et al.
Publicado: (2012)

MAPK signaling control of colon cancer metastasis
por: Urosevic, Jelena, et al.
Publicado: (2014)

To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013)

New roles of Rb1 in expansion of MDSCs in cancer
por: Youn, Je-In, et al.
Publicado: (2013)

p53 and cancer stem cells: The mevalonate connexion
por: Ginestier, Christophe, et al.
Publicado: (2012)

CRH-R splicing in estrogen-sensitive breast cancer
por: Grammatopoulos, Dimitris K
Publicado: (2014)

Mitochondrial metabolism in TCA cycle mutant cancer cells
por: Sullivan, Lucas B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h0pgtrhkbc2tasb5sb4m89cn5m